Jisc Elsevier Read and Publish Agreement 2022-2024 (redacted) | ESAC Initiative

This agreement will have a huge impact on the overall UK open access transition as it will include unlimited OA publishing in Core hybrid, Cell Press and The Lancet titles. Read access remains the same as previous 2021 subscription titles. Publishing in fully OA titles is an optional extra with 15% discount off the standard APC. Read and Publish Pricing is based on an institution’s 2021 contracted subscription spend inside and outside Jisc with a 15% reduction.